4 结果
The present invention relates to a pharmaceutical composition comprising as active ingredients
(i) the AT.sub.1 receptor antagonist (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'(1H-tetrazol-5-yl)bi phenyl-4-yl-methyl]amine (valsartan) of formula (I) ##STR1##
or a pharmaceutically acceptable
The present invention relates to a pharmaceutical composition comprising as active ingredients
(i) the AT.sub.1 receptor antagonist (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'(1H-tetrazol-5-yl)bi phenyl4-yl-methyl]amine (valsartan) of formula (I) ##STR1##
or a pharmaceutically acceptable
BACKGROUND OF THE INVENTION
The renin angiotensin system is a complex hormonal system comprised of a large molecular weight precursor, angiotensinogen, two processing enzymes, renin and angiotensin converting enzyme (ACE), and the vasoactive mediator angiotensin II (Ang II). See J. Cardiovasc.
BACKGROUND OF THE INVENTION
The renin angiotensin system is a complex hormonal system comprised of a large molecular weight precursor, angiotensinogen, two processing enzymes, renin and angiotensin converting enzyme (ACE), and the vasoactive mediator angiotensin II (Ang II). See J. Cardiovasc.